Raymond James Financial Services Advisors, Inc. Ascendis Pharma A/S Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$86.1 - $127.36 $582,552 - $861,717	-6,766 Reduced 45.14%	8,224 $1.04 Million
Q3 2023 Oct 24, 2023	BUY	$86.5 - $103.97 $452,308 - $543,659	5,229 Added 53.57%	14,990 $1.4 Million
Q2 2023 Jul 25, 2023	BUY	$69.96 - $97.84 $111,446 - $155,859	1,593 Added 19.5%	9,761 $871,000
Q1 2023 Apr 14, 2023	BUY	$104.9 - $126.78 $283,334 - $342,432	2,701 Added 49.41%	8,168 $875,000
Q4 2022 Feb 08, 2023	BUY	$99.42 - $131.97 $543,529 - $721,479	5,467 New	5,467 $667,000

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

Ra Capital Management, L.P. Boston, MA

9.71M
Shares

$1.32 Billion
20.22% of portfolio
Westfield Capital Management CO LP Boston, MA

5.13M
Shares

$700 Million
3.62% of portfolio
Avoro Capital Advisors LLC New York, NY

4.99M
Shares

$680 Million
11.21% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.41M
Shares

$602 Million
1.03% of portfolio
Janus Henderson Group PLC London, X0

4.19M
Shares

$571 Million
0.33% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account